Açaí juice attenuates atherosclerosis in ApoE deficient mice through antioxidant and anti-inflammatory activities

Atherosclerosis

Volumn 216, Issue 2, 2011, Pages 327-333

  Xie, Chenghui ^a,b   Kang, Jie ^a,b   Burris, Ramona ^a   Ferguson, Matthew E ^a   Schauss, Alexander G ^c   Nagarajan, Shanmugam ^a   Wu, Xianli ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c AIBMR Life Science Inc   (United States)

Author keywords

A a ; Antioxidant enzyme; ApoE deficient mice; Atherosclerosis; Cytokine; Euterpe oleracea Mart.; Inflammation

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYICOSATETRAENOIC ACID; HYDROXYOCTADECADIENOIC ACID; ICOSANOID; INTERLEUKIN 6; ISOPROSTANE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACAI JUICE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FRUIT JUICE; GENE EXPRESSION; GPX3 GENE; GSR GENE; LIPID PEROXIDATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANIMAL FEED; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOLIPOPROTEINS E; BEVERAGES; BIOLOGICAL MARKERS; F2-ISOPROSTANES; FATTY ACIDS, UNSATURATED; FEMALE; HYDROXYEICOSATETRAENOIC ACIDS; INTERLEUKIN-6; LIPID PEROXIDATION; MICE; MICE, TRANSGENIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79954424849     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.02.035     Document Type: Article

References (36)

1. Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997, 337:1360-1369.
2. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
3. Dauchet L., Amouyel P., Dallongeville J. Fruits, vegetables and coronary heart disease. Nat Rev Cardiol 2009, 6:599-608.
4. Galassetti P., Pontello A. Dietary effects on oxidation of low-density lipoprotein and atherogenesis. Curr Atheroscl Rep 2006, 8:523-529.
5. Hu F.B. Plant-based foods and prevention of cardiovascular disease: an overview. Am J Clin Nutr 2003, 78:544S-551S.
6. Schauss A.G., Jensen G.S., Wu X. Increased antioxidant capacity and inhibition of lipid peroxidation in healthy adults consuming an acai (Euterpe oleracea) fruit-based juice. Acta Hortic 2009, 841:97-100.
7. Jensen G.S., Wu X., Patterson K.M., et al. In vitro and in vivo antioxidant and anti-inflammatory capacities of an antioxidant-rich fruit and berry juice blend. Results of a pilot and randomized, double-blinded, placebo-controlled, crossover study. J Agric Food Chem 2008, 56:8326-8333.
8. Schauss A.G., Wu X., Prior R.L., et al. Antioxidant capacity and other bioactivities of the freeze-dried Amazonian palm berry, Euterpe oleracea Mart. (acai). J Agric Food Chem 2006, 54:8604-8610.
9. de Souza M.C., Figueiredo R.W., Maia G.A., et al. Bioactive compounds and antioxidant activity on fruits from different acai (Euterpe oleracea Mart) progenies. Acta Hortic 2009, 841:455-458.
10. Schauss A.G., Jensen G.S., Wu X. Açai (Euterpe oleracea): an Amazonian palm fruit with broad antioxidant and anti-inflammatory activities. Flavor and Health Benefits of Small Fruits, Washington 2010, American Chemical Society, pp. 212-223.
11. Matheus M.E., de Oliveira Fernandes S.B., Silveira C.S., et al. Inhibitory effects of Euterpe oleracea Mart. on nitric oxide production and iNOS expression. J Ethnopharmacol 2006, 107:291-296.
12. Meir K.S., Leitersdorf E. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 2004, 24:1006-1014.
13. Nagarajan S., Burris R.L., Stewart B.W., et al. Dietary soy protein isolate ameliorates atherosclerotic lesions in apolipoprotein E-deficient mice potentially by inhibiting monocyte chemoattractant protein-1 expression. J Nutr 2008, 138:332-337.
14. Shishehbor M.H., Zhang R., Medina H., et al. Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease. Free Radic Biol Med 2006, 41:1678-1683.
15. Unterwurzacher I., Koal T., Bonn G.K., et al. Rapid sample preparation and simultaneous quantitation of prostaglandins and lipoxygenase derived fatty acid metabolites by liquid chromatography-mass spectrometry from small sample volumes. Clin Chem Lab Med 2008, 46:1589-1597.
16. Wu X., Kang J., Xie C., et al. Dietary blueberries attenuate atherosclerosis in apolipoprotein E-deficient mice by upregulating antioxidant enzyme expression. J Nutr 2010, 140:1628-1632.
17. Thampi P., Stewart B.W., Joseph L., et al. Dietary homocysteine promotes atherosclerosis in apoE-deficient mice by inducing scavenger receptors expression. Atherosclerosis 2008, 197:620-629.
18. Nakashima Y., Plump A.S., Raines E.W., et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994, 14:133-140.
19. Tabet F., Rye K.A. High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond) 2009, 116:87-98.
20. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
21. Stocker R., Keaney J.F.J. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004, 84:1381-1478.
22. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997, 272:20963-20966.
23. Niki E., Yoshida Y., Saito Y., et al. Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun 2005, 338:668-676.
24. Meagher E.A., FitzGerald G.A. Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med 2000, 28:1745-1750.
25. Niki E. Lipid peroxidation products as oxidative stress biomarkers. Biofactors 2008, 34:171-180.
26. Patrignani P., Tacconelli S. Isoprostanes and other markers of peroxidation in atherosclerosis. Biomarkers 2005, 10(Suppl. 1):S24-S29.
27. Yoshida Y., Niki E. Bio-markers of lipid peroxidation in vivo: hydroxyoctadecadienoic acid and hydroxycholesterol. Biofactors 2006, 27:195-202.
28. Leopold J.A., Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol 2005, 25:1332-1340.
29. Wassmann S., Wassmann K., Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 2004, 44:381-386.
30. Berndt C., Lillig C.H., Holmgren A. Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am J Physiol Heart Circ Physiol 2007, 292:H1227-1236.
31. Aviram M. HDL-associated paraoxonase 1 (PON1) and dietary antioxidants attenuate lipoprotein oxidation, macrophage foam cells formation and atherosclerosis development. Pathophysiol Haemost Thromb 2006, 35:146-151.
32. Linton M.F., Fazio S. Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 2003, 27:S35-S40.
33. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
34. Szekanecz Z. Pro-inflammatory cytokines in atherosclerosis. Isr Med Assoc J 2008, 10:529-530.
35. Gotsman I., Stabholz A., Planer D., et al. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?. Isr Med Assoc J 2008, 10:494-498.
36. de Winther M.P., Kanters E., Kraal G., et al. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 2005, 25:904-914.